TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 5 | -1 | 4 | 31 | 10 | -54 | -1 |
| P | %wins | 100 | 0 | 100 | 100 | 100 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/17 16:21 | 12/14/17 | ACUR | Acura Pharmaceuticals, Inc | NY | Health | Drug | Pharmaceutical Preparations | Jones Robert B | IL | DO | P,CEO | P | 40 | 0.1000 | 0 | 400 | 999% | 413 | D | ||||||||||||||
8/17/11 07:22 | 8/15/11 | ACUR | Acura Pharmaceuticals, Inc | NY | Health | Drug | Pharmaceutical Preparations | Jones Robert B | IL | O | P,CEO | P | 10 | 3.23 | 0 | 3 | 2 | 195 | D | -44 | 26 | -3 | -28 | -17 | 3 | 4 | 16 | 5 | -1 | 4 | 31 | 10 | -54 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |